Live: Oklo 3rd Quarter Earnings Coverage
Oklo Inc. (NYSE: OKLO | OKLO Price Prediction) will report its third-quarter fiscal 2025 results after the market close. The company continues to be one of the most closely watched names in advanced nuclear…
That wraps up our initial coverage of Oklo’s Q1 results. Thank you for stopping by!
Check out management’s earnings call at 5 PM EST for more updates.
Oklo (NYSE:OKLO) insiders have been net sellers over the past 3 months.
| Date | Insider | Title | Transaction | Shares | Value |
|---|---|---|---|---|---|
| May 1, 2026 | Caroline Cochran | COO | Sale | 200,000 | $14,046,610 |
| May 1, 2026 | Jacob DeWitte | CEO | Sale | 200,000 | $14,046,390 |
| Mar 2, 2026 | Jacob DeWitte | CEO | Sale | 200,000 | $12,658,097 |
| Mar 2, 2026 | Caroline Cochran | COO | Sale | 200,000 | $12,658,097 |
| Apr 1, 2026 | Jacob DeWitte | CEO | Sale | 200,000 | $10,069,852 |
Activity skews overwhelmingly toward selling, with roughly 178 sales and zero open-market purchases across the past six months.
Co-founders DeWitte and Cochran have each unloaded 200,000 shares monthly under 10b5-1 plans adopted March 31, 2025. CFO Bealmear, CTO Schweiger, and CLO Goodwin also trimmed; directors Peters, Kan, Park, and Christian received RSU grants April 10.
Pre-planned cadence softens the signal, yet insiders are choosing to monetize the run-up rather than buy more.
With Q1 results now public, here are the Bull and Bear cases for Oklo:
With Q1 results out, attention shifts to the next set of catalysts that will determine whether Oklo’s recent 55.48% one-month rally holds.
The average analyst price target sits at $91.36, with 15 buy ratings outweighing 5 hold calls. Execution on Groves and Aurora milestones will decide whether that gap closes.
Oklo reported Q1 adjusted EPS of -$0.19 versus estimates of -$0.18, while again reporting no commercial revenue as Aurora remains pre-operational.
The bigger development came earlier this week when the NRC accelerated approval of Aurora’s Principal Design Criteria, a key licensing milestone that helps establish safety and performance standards for future deployment.
Investors remain focused on whether Oklo can reach commercial operation before needing additional large capital raises, especially as AI-driven hyperscaler power demand continues accelerating.
Oklo just reported earnings. Here are the key numbers:
Quick read:
Management also highlighted growing demand from data center, utility, industrial, and oil & gas customers.
Shares are initially down 3% following the report.
Analysts’ average price target is currently $91.36, while the stock trades around $73.56.
Oklo’s last earnings report largely removed financing concerns around the business. The company exited 2025 with roughly $1.4 billion in cash and marketable securities, then added another $1.18 billion through its ATM program in January. Total liquidity now sits near $2.5 billion, versus expected 2026 cash burn of just $80 million to $100 million.
Regulatory progress also accelerated in March, with DOE approval for the Aurora-INL Nuclear Safety Design Agreement and an NRC materials license for Oklo’s Atomic Alchemy subsidiary. Management expects Atomic Alchemy to generate its first revenue in 2026.
Oklo continues standing out in the SMR (small modular reactors) space because of its business model.
Most SMR companies sell reactors to customers, while Oklo plans to own and operate reactors itself and sell electricity directly through long-term agreements. That gives Oklo exposure to recurring power revenue instead of one-time equipment sales.
The global SMR offtake pipeline has climbed to roughly 45 GW as hyperscalers race to secure future AI power capacity. Oklo is also using the DOE Reactor Pilot Program for parts of its licensing process, which could help accelerate deployment timelines relative to peers.
Oklo’s Q4 earnings tonight could become a major catalyst for the stock.
Shares trade near $74, down roughly 50% from the stock’s October 2025 high near $174, despite continued progress across commercial agreements and nuclear demand trends. Meta signed a 1.2 GW power agreement with Oklo in January, while EPRI now projects data centers could consume 9-17% of U.S. electricity by 2030.
The market’s hesitation comes down to timing, with Oklo not expected to deliver its first power until 2027. Investors will now look for updates on Aurora-INL, the July 2026 criticality target, and the long-rumored OpenAI partnership.
Oklo (NYSE:OKLO) reports at 4 PM ET after the bell tonight.
Analysts’ average price target sits at $91.36, with shares down 5.93% today to $73.83.
Oklo shares are up 178% over the past year as investors increasingly price in a credible path toward commercial advanced nuclear deployment. The company now has NRC Principal Design Criteria approval in hand, a growing customer pipeline, and strategic relationships tied to rising AI-driven power demand.
This quarter matters because the focus shifts from regulatory progress toward commercial execution.
Investors want to see whether Atomic Alchemy begins contributing early radioisotope revenue, whether the Aurora licensing timeline continues to support targeted 2027 to 2028 deployment, and whether operating cash burn remains controlled as development activity ramps up.
If management delivers measurable progress across commercialization, licensing, and deployment readiness, Oklo’s long-term thesis will strengthen materially.
Live coverage has ended. The full story is below.
Investors are watching Oklo (NYSE: OKLO | OKLO Price Prediction) ahead of its Q1 2026 results due Tuesday, May 12, at 4:00 PM ET. The advanced nuclear developer enters this report with shares up 55.48% in a month and a fresh Nvidia collaboration in hand.
Two catalysts have powered the stock’s recent rally. First, on April 23, Oklo and NVIDIA announced a partnership to advance nuclear fuel validation at Los Alamos in support of nuclear-powered AI factories. Then on May 6, the NRC approved the Principal Design Criteria Topical Report for the Aurora Powerhouse, a key step toward the combined license application.
Oklo remains pre-revenue, with FY2025 showing a net loss of roughly $105.7 million, an operating loss of $139.3 million, and approximately $1.4 billion in cash and marketable securities at year-end following major capital raises. The company’s customer pipeline has expanded to roughly 15 GW, supported by a 12 GW non-binding master power agreement with Switch through 2044 and a new partnership with Meta tied to a planned 1.2 GW nuclear-powered data center campus in Ohio.
| Metric | Estimate | Comparison |
|---|---|---|
| Q1 2026 EPS (most recent published consensus) | -$0.0699 | vs Q3 2024 actual -$0.08 |
| Q1 2026 Revenue | $0 (pre-commercial) | Atomic Alchemy could contribute first $ |
| FY2026 Forward EPS | -$0.76 | vs FY2024 -$0.74 |
| FY2026 Revenue | Optional radioisotope launch | vs $0 in FY2024 |
I’ll be primarily watching three things tonight. First, whether Atomic Alchemy contributes to revenue. CEO Jake DeWitte previously told investors the radioisotope demonstration project “could begin generating revenue as early as the first quarter of 2026,” which would mark Oklo’s first commercial revenue stream. Even a modest contribution would matter for a company still largely valued on future deployment potential rather than operating results.
Second, the focus shifts from application readiness toward execution of the NRC review process itself. Oklo completed the NRC’s pre-application readiness assessment in 2025. Since then, the company has continued to advance key licensing milestones, including topical report approvals and Principal Design Criteria acceptance, under accelerated timelines. Investors now want proof that these regulatory wins can translate into a credible path toward commercial deployment at Idaho National Laboratory in late 2027 to 2028.
Third, cash burn and capital positioning. FY2025 operating cash flow burn accelerated as Oklo expanded engineering, licensing, and commercialization efforts tied to Aurora deployment and fuel recycling initiatives. However, the company ended the year with roughly $1.4 billion in cash and marketable securities following major equity raises, giving management a much larger balance sheet cushion than it had entering 2025.
Contact [email protected] for any questions or corrections.
Oklo Inc. (NYSE: OKLO | OKLO Price Prediction) will report its third-quarter fiscal 2025 results after the market close. The company continues to be one of the most closely watched names in advanced nuclear…
Oklo just posted its first real quarterly revenue and the stock surged, yet shares still sit 33% in the red for the year. A return to triple digits is mathematically possible, but it hinges…
Investors who are watching nuclear energy stocks are keeping a close eye on shares of Oklo (NYSE:OKLO | OKLO Price Prediction), which are down 24% over the past month and trade near $66, well…
Oklo has shed more than 70% from its peak while simultaneously landing federal AI-nuclear contracts and a massive hyperscaler pipeline that rivals see as the future of data center power. Whether that gap is…
Shares of Oklo (NYSE:OKLO | OKLO Price Prediction) are up roughly 13% in midday trading Wednesday after the U.S. Nuclear Regulatory Commission (NRC) approved the Principal Design Criteria for the company’s Aurora powerhouse. The…
A Nuclear Surge Ignites Investor Frenzy On Friday, shares of Oklo (NYSE:OKLO | OKLO Price Prediction) and NuScale Power (NYSE:SMR) blasted over 20% higher, electrified by the U.S.-U.K. Atlantic Partnership for Advanced Nuclear Energy,…
Oklo (NYSE: OKLO) reports first-quarter results this evening with investor focus centered on regulatory progress, early-stage commercial traction, and its growing clean energy pipeline. While the company is still pre-revenue, analysts will be watching…
I’ll cut to the chase. Oklo (NYSE:OKLO | OKLO Price Prediction) trades at $57.49, well off its 52-week high of $193.84, and our proprietary model still sees real upside from here. Our 24/7 Wall…
Oklo (NYSE:OKLO | OKLO Price Prediction) stock advanced 5% Tuesday morning, with shares testing the $63 level after closing Monday at $59.69. In a more muted move, NuScale Power (NYSE:SMR) stock rose 3% with…